Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

The newest case is the fifth to bring similar allegations against Moderna in the same court, with three others, all filed Nov ...

In immunocompetent individuals, adjusted vaccine effectiveness reached 80% (95% CI 71-85) against RSV-associated hospitalizations, 81% (95% CI 52-92) against associated critical illness (intensive ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The CDC recommends a single dose of any FDA-approved ...

the company reported that a single 120µg dose of the vaccine led to “strong neutralising” responses against RSV-A and RSV-B. The commonly reported treatment-associated side effects were pain ...

The retrospective cohort study evaluated the effects of the RSV vaccine in patients diagnosed with IBD aged older than 60 years using data from the TriNetX database. The participants were grouped ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

The most common side effects are mild—including headache, fatigue, and redness at the injection site—and the antibodies produced in response to a maternal RSV vaccine will continue to protect ...